Selonsertib

DRUG4 trials

Sponsors

Gilead Sciences

Conditions

Alcoholic Hepatitis (AH)Diabetic Kidney DiseasePulmonary Arterial Hypertension

Phase 1

Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function

CompletedNCT02509624

Gilead SciencesDiabetic Kidney Disease

Start: 2015-08-18End: 2015-12-15Updated: 2021-01-27

Phase 2

Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease

CompletedNCT02177786

Gilead SciencesDiabetic Kidney Disease

Start: 2014-06-30End: 2016-08-31Updated: 2019-11-05

Selonsertib in Adults With Pulmonary Arterial Hypertension

CompletedNCT02234141

Gilead SciencesPulmonary Arterial Hypertension

Start: 2014-11-30End: 2016-12-31Updated: 2019-04-10

Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)

CompletedNCT02854631

Gilead SciencesAlcoholic Hepatitis (AH)

Start: 2016-09-01End: 2018-05-31Updated: 2019-02-06

Related Papers

Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial.

2021-08-2026 citations